Results 221 to 230 of about 60,446 (233)

Functional competency of a novel 2-ply vacuum-pressed biological scaffold for entire posterior mitral valve reconstruction. [PDF]

Sci Rep
Jedrzejczyk JH, Andersen FT, Kaspersen AE, Væsel JT, Ammitzskov DO, Skov SN, Hasenkam JM, Tjørnild MJ.   +7 more
europepmc   +1 more source

Effects of sodium–glucose co‐transporter inhibitors on individual clinical endpoints and quality of life

ESC Heart Failure, Volume 12, Issue 2, Page 1271-1282, April 2025.
Effects of SGLTi on Individual Clinical Endpoints and Quality‐of‐Life: outcome from randomized data. Abstract Aims Sodium–glucose co‐transporter inhibitors (SGLTis) have cardiovascular protective effects. We aimed to assess the effects of SGLTis on individual hard clinical endpoints and quality of life (QoL) in patients with cardiovascular risk factors.
Jia Liao, Yang Chen, Zhiyu Ling, Helmut Pürerfellner, Martin Martinek, Michael Derndorfer, Johannes Niel, Ramin Ebrahimi, Matthias Heukäufer, Sarah Janschel, Davide Di Vece, Klaus Empen, Astrid Hummel, Bishwas Chamling, Piotr Futyma, Fahim Ebrahimi, Márcio G. Kiuchi, Shaowen Liu, Yuehui Yin, Alexandra Schratter, Willem‐Jan Acou, Philipp Sommer, Boris Schmidt, Julian K. R. Chun, Christian Meyer, Marcus Dörr, Christian Templin, Shaojie Chen   +27 more
wiley   +1 more source

Transvenous Lead Extraction for Tricuspid Regurgitation and Right Atrial Enlargement Induced by an Atrial Lead. [PDF]

JACC Case Rep
Wakasa S, Yoshiyama T, Hirayama S, Fukuda K, Yanagishita T, Ogawa M, Hayashi Y, Fukuda D.   +7 more
europepmc   +1 more source

Considerations for drug trials in hypertrophic cardiomyopathy

ESC Heart Failure, Volume 12, Issue 2, Page 1095-1112, April 2025.
Abstract Hypertrophic cardiomyopathy (HCM) is a heterogeneous condition with potentially serious manifestations. Management has traditionally comprised therapies to palliate symptoms and implantable cardioverter‐defibrillators to prevent sudden cardiac death. The need for disease‐modifying therapies has been recognized for decades.
John P. Farrant, Matthias Schmitt, Anna B. Reid, Clifford J. Garratt, William G. Newman, Aneil Malhotra, Rhys Beynon, Masliza Mahmod, Betty Raman, Robert M. Cooper, Dana Dawson, Thomas Green, Sanjay K. Prasad, Anvesha Singh, Susanna Dodd, Hugh Watkins, Stefan Neubauer, Christopher A. Miller   +17 more
wiley   +1 more source

Robustness of heart dose against cardiac cycle in breast cancer radiotherapy with deep inspiration breath-hold. [PDF]

Radiol Phys Technol
Yanagi Y, Monzen H, Aoki K, Harada N, Ohashi K, Hayashi M, Kosaka H, Iguchi H.   +7 more
europepmc   +1 more source

Reframing the role of glucagon‐like peptide 1 receptor agonists in cardiovascular medicine

ESC Heart Failure, Volume 12, Issue 2, Page 923-926, April 2025.
Riccardo M. Inciardi, Alvin Chandra, Ambarish Pandey, Marco Metra   +3 more
wiley   +1 more source

Using Patient-Based Computational Fluid Dynamics for Abdominal Aortic Aneurysm Assessment. [PDF]

Bioengineering (Basel)
Kaewchoothong N, Rookkapan S, Nuntadusit C, Chatpun S.   +3 more
europepmc   +1 more source

Assessment of atrial septal defect size during systole and diastole using 4D CT: a case series. [PDF]

AME Case Rep
Nishimoto Y, Kawase T, Fujii R, Nangoya R, Nagao M, Noda K, Inno G, Nishiya K, Takahashi Y.   +8 more
europepmc   +1 more source

Associations of High-Sensitivity Cardiac Troponin and N-Terminal Pro-B-Type Natriuretic Peptide With Echocardiographic Features in Patients With Hypertension. [PDF]

J Clin Hypertens (Greenwich)
Wang M, Li X, Qiu L, Wang Z, Li J, Sun J, Han L, Yang N, Hao Y, Hu R, Qi Y, Liu J.   +11 more
europepmc   +1 more source

Radiofrequency Catheter Ablation for Arrhythmia-induced Cardiomyopathy in Infants: A Case Series and Literature Review. [PDF]

Arrhythm Electrophysiol Rev
Li X, Shu W, Hou M, Lv H, Xu Q, Wang B, Sun L, Tan J, Chen Y, Zhou W.   +9 more
europepmc   +1 more source